Category European Union

Using the outcome of Case T-611/18 (Pharmaceutical Works Polpharma S.A vs the EMA) to better understand aspects of EU medicines legislation

Last updated: 21 December 2023 See updates at the end of the post. The parties involved in the case The parties involved in this case were Pharmaceutical Works Polpharma S.A versus the European Medicines Agency (Case T-611/18) supported by the…

Read MoreUsing the outcome of Case T-611/18 (Pharmaceutical Works Polpharma S.A vs the EMA) to better understand aspects of EU medicines legislation

Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational in the EU

Last updated: 9 July 2024 See updates at the end of the post. On 1 July 2022, the transitional period for the application of the Supplementary Protection Certificate (SPC) manufacturing waiver ended. The SPC manufacturing waiver became operational from 2…

Read MoreSupplementary Protection Certificate (SPC) manufacturing waiver becomes operational in the EU